Drugs / rgp120/HIV-1 SF-2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00000871 | ? → Jan 2000 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rgp120/HIV-1 SF-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000871 ↗ |
| Known as | SF-2 rgp120 | “Group A- ALVAC vCP205 plus SF-2 rgp120 in MF59.” NCT00000871 ↗ |